DeRitis ratio is associated with unfavorable prognosis in ACS patients
Frontiers in Cardiovascular Medicine · 17.03.2026 · 13
DOI: 10.3389/fcvm.2026.1690027 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Cardiovascular Medicine, online erschienen am 17.03.2026. Verfasst von Yi Fang und 5 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Frigid Zone Cardiovascular Disease, Cardiovascular Research Institute and Department of Cardiology, General Hospital of North…. Die Arbeit nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
The aspartate aminotransferase (AST) to alanine aminotransferase (ALT) ratio, commonly referred to as the DeRitis ratio, serves as an indicator of liver disease severity and has been linked to several cardiovascular risk factors. This study aimed to explore the relationship between the DeRitis ratio (AST/ALT) and long-term adverse outcomes in patients diagnosed with acute coronary syndrome (ACS).
Methods
We selected 8,429 patients with ACS from the OPT-CAD database who were admitted between 2012 and 2014 and had complete AST and ALT measurements. Following propensity score matching (PSM), 5,680 patients were included in the final analysis. A retrospective survival analysis was conducted to evaluate the relationship between the DeRitis ratio and the occurrence of net adverse clinical events (NACE) within 5 years post-discharge. The primary outcome was NACE, defined as a composite of all-cause mortality, stroke, non-fatal myocardial infarction (MI), and major bleeding [Bleeding Academic Research Consortium (BARC) types 2–5].
Results
Following PSM, the cumulative incidence of NACE within 5 years was significantly higher in the group with a DeRitis ratio ≥1 compared to the group with a DeRitis ratio <1 (HR: 1.21; 95% CI: 1.05–1.38; P = 0.0071). After adjusting for confounding factors using Cox multivariable analysis, the association persisted as significant (HR: 1.21; 95% CI: 1.06–1.39; P = 0.006). Subgroup analysis indicated that the high-ratio group had a significantly increased risk of major bleeding (HR: 1.27; 95% CI: 1.01–1.59; P = 0.037). However, the cumulative risk of all-cause death showed a strong trend towards increase but did not reach statistical significance (HR: 1.23; 95% CI: 0.99–1.51; P = 0.052). There were no significant differences between the groups in the cumulative risks of non-fatal myocardial infarction (MI) (HR: 1.22; 95% CI: 0.89–1.67; P = 0.21), or stroke (HR: 1.01; 95% CI: 0.78–1.32; P = 0.92).
Conclusion
The DeRitis ratio ≥1 is significantly associated with elevated risk of NACE during the 5-year post-discharge period in ACS patients. Additionally, an elevated DeRitis ratio is correlated with a higher incidence of major bleeding events.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- State Key Laboratory of Frigid Zone Cardiovascular Disease, Cardiovascular Research Institute and Department of Cardiology, General Hospital of Northern Theater Command, Shenyang, China.
- Department of Cardiology, Shenyang Ninth People's Hospital, Shenyang, China.
Zitieren
APA
Fang, Y., Zhang, C., Liu, H., Li, Y., Qiu, M., & Xu, K. (2026). DeRitis ratio is associated with unfavorable prognosis in ACS patients. Frontiers in Cardiovascular Medicine, 13. https://doi.org/10.3389/fcvm.2026.1690027
Vancouver
Fang Y, Zhang C, Liu H, Li Y, Qiu M, Xu K. DeRitis ratio is associated with unfavorable prognosis in ACS patients. Frontiers in Cardiovascular Medicine. 2026;13. doi:10.3389/fcvm.2026.1690027
BibTeX
@article{Fang2026,
author = {Fang, Yi and Zhang, Chensong and Liu, Haiwei and Li, Yang and Qiu, Miaohan and Xu, Kai},
title = {DeRitis ratio is associated with unfavorable prognosis in ACS patients},
journal = {Frontiers in Cardiovascular Medicine},
year = {2026},
volume = {13},
doi = {10.3389/fcvm.2026.1690027}
}
EUVIMED